Broomfield, CO, June 04, 2016 --(PR.com
)-- MedAware Systems, Inc. announced today that Dr. Jeff Thompson is joining the Company’s Scientific Advisory Board.
Dr. Thompson is the former Chief Executive Officer and Chairman of the Board of Gundersen Health System. He is an internationally recognized leader in healthcare quality. A founding member and past board chair of the Wisconsin Collaborative for Healthcare Quality and a 2013 White House Champion of Change, Dr. Thompson has led Gundersen's internationally-recognized initiatives for patient care, quality improvement and sustainability. Presently, he serves as Executive Advisor and CEO Emeritus for Gundersen Health System and on the Board of Directors for Practice Greenhealth.
Dr. Thompson is board certified in pediatric critical care, neonatal and perinatal medicine, and pediatrics. He is a member of the American Academy of Pediatrics, as well as their subsections in neonatal and critical care medicine, and is a member of American College of Physician Executives. He has authored numerous articles, book chapters and abstracts on a wide range of healthcare topics.
“We are thrilled to have Dr. Thompson join our Scientific Advisory Board. He has been at the forefront of impactful change and meaningful innovation in healthcare. Under his 14 years of leadership, Gundersen Health System transformed into one of the world’s leading healthcare organizations and was the only healthcare organization invited to participate at the Paris Climate talks in 2015,” said Peter Nichol, MD, PhD, Chair of MedAware Systems’ Scientific Advisory Board. He adds, “With his tremendous knowledge and thought leadership in healthcare, Dr. Thompson will be a key partner in MedAware’s Mission to transform healthcare.”
About MedAware Systems, Inc.
MedAware Systems is a leading company in evidence-based medical treatment efficacy information. The Company’s Personalized Clinical Decision Support system is a Scientific-Data-as-a-Service (SDaaS)™ that solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable in developing the patient plan of care. The Company aggregates, organizes, and standardizes data from all human clinical trials across various disease/condition areas to provide immediate and actionable information on evidence-based medical treatments and outcomes.